Related Experiment Videos
HPV proteins as targets for therapeutic intervention
Helena Sterlinko Grm1, Lawrence Banks
1International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Antiviral Therapy
|November 13, 2004
Summary
Human papillomaviruses (HPV) cause anogenital tumors, cervical cancer, and skin cancers. Targeting viral proteins offers a promising therapeutic strategy for HPV infections and associated cancers.
Area of Science:
- Oncology
- Virology
- Dermatology
Background:
- Human papillomaviruses (HPV) are linked to anogenital tumors, notably cervical carcinoma.
- Emerging evidence implicates HPV in skin squamous cell carcinomas, particularly in immunocompromised individuals.
- HPV infections also cause non-malignant, aesthetically concerning lesions.
Purpose of the Study:
- To review the functions of viral proteins relevant for therapeutic development against HPV infections.
- To explore therapeutic strategies targeting HPV-induced diseases, including cancers and benign lesions.
Main Methods:
- This review synthesizes current research on HPV viral protein functions.
- Literature analysis focusing on protein targets for antiviral and anticancer therapies.
Main Results:
- Specific HPV viral proteins are identified as key targets for therapeutic intervention.
- Understanding protein functions is crucial for developing effective treatments.
Conclusions:
- Targeting HPV viral proteins presents a viable strategy for treating HPV infections and related malignancies.
- Development of therapeutics against HPV holds significant humanitarian and economic benefits.